McKesson, Wal-Mart launch sourcing agreement for generic drugs

Health IT corporation McKesson and retail giant Wal-Mart have signed a sourcing agreement for generic pharmaceuticals and an expanded long-term distribution agreement.

The organizations will collaborate on sourcing generic pharmaceuticals for their respective U.S. operations. The new sourcing agreement leverages McKesson's demonstrated strength and expertise in the global pharmaceutical industry and Wal-Mart's proven commitment to delivering high-quality and low-cost health and wellness services to its customers.

"McKesson and Wal-Mart have worked together for decades and throughout our relationship both companies have engaged in an ongoing dialogue about how we can work together to bring more efficiency and value to the healthcare supply chain," said Mark Walchirk, president of McKesson U.S. Pharmaceutical. "Expanding our relationship to include a sourcing partnership for generics makes economic and strategic sense for both of us — by bringing together our respective scale and sourcing expertise, we will make our businesses stronger and create more value for our customers and patients."

More articles on supply chain:
How automation, analytics and interoperability reduce costs in the cardiac cath lab
6 ways to reevaluate how your hospital manages high-value medical products
Shortages of critical drugs in the ER persist

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months